GlucoTrack is a medical technology company whose two-year implantable Continuous Blood Glucose Monitoring (CBGM) technology provides discreet, accurate, real-time glucose readings. The company's ...

Senseonics has revealed promising results for its Eversense technology, a long-term implantable continuous glucose monitoring (CGM) system. The PRECISE II trial looked at the safety and ...

The CBGM is a long-term implantable device with no on-body external component. It is designed to provide three years of continuous, accurate blood glucose monitoring, offering a more convenient and ...

The Glucotrack Continuous Blood Glucose Monitor is a long-term implantable device for continuous blood glucose monitoring without external components. When will Glucotrack present its trial data?

Glucotrack (Nasdaq:GCTK) may be bringing its continuous blood glucose monitor (CBGM) technology to automated insulin delivery ...

(Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that ...

To test the sensor accuracy, the researchers implanted it onto the skin of a hairless diabetic ... Forlenza does research with Medtronic and Dexcom, which both manufacture blood glucose monitoring ...

The CBGM is a long-term implantable device with no on-body external component. It is designed to provide three years of continuous, accurate blood glucose monitoring, offering a more convenient ...

Morningstar brands and products Company Portfolio ...